Phase I safety and acceptability study of the investigational vaginal microbicide PRO 2000/5 gel (P).
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2017
At a glance
- Drugs PRO 2000 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 01 Dec 2006 Status change
- 25 Oct 2005 New trial record.